President Donald Trump, who has been promising big changes at FDA, said he has a "fantastic person" lined up for the role of FDA commissioner that will be named soon.
The likely candidates, as reported by Business Insider, include Jim O'Neill, Dr. Scott Gottlieb, and Dr. Joseph Gulfo.
Jim O'Neill, managing director at Mithril Capital, a libertarian who has said he's in favor of approving drugs that are safe, before they're shown to be effective.
Dr. Scott Gottlieb, a resident fellow at the American Enterprise Institute and former deputy commissioner of the FDA during George W. Bush's presidency. Gottlieb has emerged as a favorite among drug executives.
Dr. Joseph Gulfo, a former biotech executive who advocates for a color-coded approval system.
Latest from Quality Assurance & Food Safety
- FDA, CDC Investigate Salmonella Outbreak Linked to Live It Up Dietary Supplement Powder
- USDA FSIS Announces New Deputy Administrator of Field Operations
- ProVeg Incubator Launches Fast-Track to Impact Program for Alt-Protein Startups
- Kerry Releases 2026 Global Taste Charts
- FDA Shares Australia Certificate Requirements for Bivalve Molluscs and Related Products
- FDA Announces Update from CFIA on Certificate Requirements for Certain Meat, Poultry Products
- NIMA Partners Introduces the Next-Generation NIMA Gluten Sensor
- IFT to Host Community Conversation on Dietary Guidelines for Americans, 2025-2030 Report
